Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,171.8, with a 24-hour trading volume of $13.29M. The asset's market cap is $1.04T, after moving 0.22% in the last day.
Tokenized Eli Lilly And Co is trading at $1,179.82, with a tokenized market cap of $45.81M and a 24-hour trading volume of $2.29M. The tokenized asset has moved 1.26% in the past 24 hours.